Titre : Protéines Escherichia coli

Protéines Escherichia coli : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multicenter Studies as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines Escherichia coli : Questions médicales les plus fréquentes", "headline": "Protéines Escherichia coli : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines Escherichia coli : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-28", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines Escherichia coli" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines bactériennes", "url": "https://questionsmedicales.fr/mesh/D001426", "about": { "@type": "MedicalCondition", "name": "Protéines bactériennes", "code": { "@type": "MedicalCode", "code": "D001426", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.097" } } }, "about": { "@type": "MedicalCondition", "name": "Protéines Escherichia coli", "alternateName": "Escherichia coli Proteins", "code": { "@type": "MedicalCode", "code": "D029968", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peter L Freddolino", "url": "https://questionsmedicales.fr/author/Peter%20L%20Freddolino", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan, United States of America." } }, { "@type": "Person", "name": "Lei Yin", "url": "https://questionsmedicales.fr/author/Lei%20Yin", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Epidemic Diseases Research Center of Anhui Province, Institute of Animal Husbandry and Veterinary Science, Anhui Academy of Agricultural Sciences, Hefei, Anhui 230031, China." } }, { "@type": "Person", "name": "Xiaocheng Pan", "url": "https://questionsmedicales.fr/author/Xiaocheng%20Pan", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Epidemic Diseases Research Center of Anhui Province, Institute of Animal Husbandry and Veterinary Science, Anhui Academy of Agricultural Sciences, Hefei, Anhui 230031, China. Electronic address: pxcpyq@sina.com." } }, { "@type": "Person", "name": "Kezong Qi", "url": "https://questionsmedicales.fr/author/Kezong%20Qi", "affiliation": { "@type": "Organization", "name": "Anhui Province Key Laboratory of Veterinary Pathobiology and Disease Control, College of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, PR China. Electronic address: qkz@ahau.edu.cn." } }, { "@type": "Person", "name": "Eduardo A Ceccarelli", "url": "https://questionsmedicales.fr/author/Eduardo%20A%20Ceccarelli", "affiliation": { "@type": "Organization", "name": "Instituto de Biología Molecular y Celular de Rosario (IBR), CONICET, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Incidence, risk factors and outcome of acute kidney injury in critically ill COVID-19 patients in Tyrol, Austria: a prospective multicenter registry study.", "datePublished": "2023-10-14", "url": "https://questionsmedicales.fr/article/37837501", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40620-023-01760-3" } }, { "@type": "ScholarlyArticle", "name": "Artificial intelligence-enhanced 12-lead electrocardiography for identifying atrial fibrillation during sinus rhythm (AIAFib) trial: protocol for a multicenter retrospective study.", "datePublished": "2023-10-11", "url": "https://questionsmedicales.fr/article/37886735", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcvm.2023.1258167" } }, { "@type": "ScholarlyArticle", "name": "Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.", "datePublished": "2023-10-11", "url": "https://questionsmedicales.fr/article/37850080", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/JHC.S428980" } }, { "@type": "ScholarlyArticle", "name": "The impact of a structured assessment and decision tool (I-DECIDED®) on improving care of peripheral intravenous catheters: A multicenter, interrupted time-series study.", "datePublished": "2023-09-09", "url": "https://questionsmedicales.fr/article/37801935", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijnurstu.2023.104604" } }, { "@type": "ScholarlyArticle", "name": "A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.", "datePublished": "2023-09-08", "url": "https://questionsmedicales.fr/article/37682775", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/DCR.0000000000002931" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines bactériennes", "item": "https://questionsmedicales.fr/mesh/D001426" }, { "@type": "ListItem", "position": 5, "name": "Protéines Escherichia coli", "item": "https://questionsmedicales.fr/mesh/D029968" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines Escherichia coli - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines Escherichia coli", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines Escherichia coli", "description": "Comment diagnostiquer une infection par E. coli ?\nQuels tests sont utilisés pour détecter les protéines E. coli ?\nQuels symptômes indiquent une infection par E. coli ?\nLes tests sanguins sont-ils utiles pour E. coli ?\nComment différencier E. coli des autres bactéries ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines Escherichia coli", "description": "Quels sont les symptômes d'une intoxication alimentaire par E. coli ?\nE. coli peut-elle causer des infections urinaires ?\nQuels signes indiquent une infection grave par E. coli ?\nLes symptômes d'E. coli varient selon le type ?\nComment les symptômes d'E. coli se manifestent-ils chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines Escherichia coli", "description": "Comment prévenir les infections à E. coli ?\nLes aliments crus sont-ils un risque pour E. coli ?\nLe lavage des mains réduit-il le risque d'E. coli ?\nFaut-il cuire la viande pour éviter E. coli ?\nLes voyages augmentent-ils le risque d'infection par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines Escherichia coli", "description": "Quel est le traitement standard pour une infection par E. coli ?\nLes antibiotiques sont-ils toujours nécessaires pour E. coli ?\nComment traiter la déshydratation due à E. coli ?\nY a-t-il des traitements spécifiques pour les souches E. coli pathogènes ?\nLes probiotiques aident-ils après une infection par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines Escherichia coli", "description": "Quelles sont les complications possibles d'une infection par E. coli ?\nE. coli peut-elle causer des complications rénales ?\nComment les complications d'E. coli sont-elles traitées ?\nLes complications d'E. coli sont-elles fréquentes ?\nQuels facteurs augmentent le risque de complications par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines Escherichia coli", "description": "Quels sont les principaux facteurs de risque d'infection par E. coli ?\nLes personnes âgées sont-elles plus à risque d'E. coli ?\nLes enfants sont-ils plus vulnérables aux infections à E. coli ?\nLe système immunitaire affaibli augmente-t-il le risque d'E. coli ?\nLes voyages à l'étranger augmentent-ils le risque d'E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par E. coli ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par culture bactérienne et tests de sensibilité aux antibiotiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les protéines E. coli ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests immunologiques et des techniques de biologie moléculaire sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection par E. coli ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée, douleurs abdominales et parfois fièvre." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour E. coli ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent détecter des signes d'infection systémique." } }, { "@type": "Question", "name": "Comment différencier E. coli des autres bactéries ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques spécifiques et des méthodes moléculaires permettent cette différenciation." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication alimentaire par E. coli ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des crampes abdominales, diarrhée sanglante et vomissements." } }, { "@type": "Question", "name": "E. coli peut-elle causer des infections urinaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, E. coli est une cause fréquente d'infections urinaires, provoquant douleur et brûlures." } }, { "@type": "Question", "name": "Quels signes indiquent une infection grave par E. coli ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la déshydratation sévère, la confusion ou la fièvre élevée sont préoccupants." } }, { "@type": "Question", "name": "Les symptômes d'E. coli varient selon le type ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, différents types d'E. coli peuvent provoquer des symptômes variés, allant de légers à graves." } }, { "@type": "Question", "name": "Comment les symptômes d'E. coli se manifestent-ils chez les enfants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Chez les enfants, les symptômes peuvent inclure diarrhée, vomissements et irritabilité." } }, { "@type": "Question", "name": "Comment prévenir les infections à E. coli ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une bonne hygiène alimentaire et le lavage des mains." } }, { "@type": "Question", "name": "Les aliments crus sont-ils un risque pour E. coli ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les aliments crus, notamment la viande et les légumes, peuvent être contaminés par E. coli." } }, { "@type": "Question", "name": "Le lavage des mains réduit-il le risque d'E. coli ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un lavage des mains régulier réduit significativement le risque d'infection." } }, { "@type": "Question", "name": "Faut-il cuire la viande pour éviter E. coli ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cuire la viande à la bonne température élimine le risque d'infection par E. coli." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection par E. coli ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des régions à risque peuvent augmenter l'exposition à E. coli." } }, { "@type": "Question", "name": "Quel est le traitement standard pour une infection par E. coli ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut l'hydratation et, dans certains cas, des antibiotiques." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils toujours nécessaires pour E. coli ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas toujours recommandés, surtout pour les souches productrices de toxines." } }, { "@type": "Question", "name": "Comment traiter la déshydratation due à E. coli ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation est traitée par des solutions de réhydratation orale ou intraveineuse." } }, { "@type": "Question", "name": "Y a-t-il des traitements spécifiques pour les souches E. coli pathogènes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches nécessitent des traitements spécifiques basés sur leur résistance aux antibiotiques." } }, { "@type": "Question", "name": "Les probiotiques aident-ils après une infection par E. coli ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques peuvent aider à restaurer la flore intestinale après une infection." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection par E. coli ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le syndrome hémolytique et urémique, et des infections systémiques." } }, { "@type": "Question", "name": "E. coli peut-elle causer des complications rénales ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches d'E. coli peuvent entraîner des complications rénales graves." } }, { "@type": "Question", "name": "Comment les complications d'E. coli sont-elles traitées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement des complications peut nécessiter des soins intensifs et des interventions médicales." } }, { "@type": "Question", "name": "Les complications d'E. coli sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes vulnérables." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications par E. coli ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les jeunes enfants, les personnes âgées et celles avec un système immunitaire affaibli sont à risque." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection par E. coli ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent la consommation d'aliments contaminés et le contact avec des animaux." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque d'E. coli ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru d'infections graves par E. coli." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux infections à E. coli ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants sont plus susceptibles de développer des infections graves." } }, { "@type": "Question", "name": "Le système immunitaire affaibli augmente-t-il le risque d'E. coli ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un système immunitaire affaibli augmente le risque d'infections et de complications." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque d'E. coli ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des pays avec des normes sanitaires faibles augmente le risque d'infection." } } ] } ] }

Sources (10000 au total)

Incidence, risk factors and outcome of acute kidney injury in critically ill COVID-19 patients in Tyrol, Austria: a prospective multicenter registry study.

Acute kidney injury is a frequent complication in critically ill patients with and without COVID-19. The aim of this study was to evaluate the incidence of, and risk factors for, acute kidney injury a... This multicenter prospective registry study included adult patients with a SARS-CoV-2 infection confirmed by polymerase chain reaction, who were treated in one of the 12 dedicated intensive care units... In total, 1042 patients were included during the study period. The median age of the overall cohort was 66 years. Of the included patients, 267 (26%) developed acute kidney injury during their intensi... As in non-COVID-19 patients, acute kidney injury is clearly associated with increased mortality in critically ill COVID-19 patients. Among known risk factors, invasive mechanical ventilation has been ...

Artificial intelligence-enhanced 12-lead electrocardiography for identifying atrial fibrillation during sinus rhythm (AIAFib) trial: protocol for a multicenter retrospective study.

Atrial fibrillation (AF) is the most common arrhythmia, contributing significantly to morbidity and mortality. In a previous study, we developed a deep neural network for predicting paroxysmal atrial ... We will conduct a retrospective cohort study of more than 50,000 12-lead ECGs from November 1, 2012, to December 31, 2021, at 10 Korean University Hospitals. Data will be collected from patient record... This study will advance PAF prediction based on AI-enhanced ECGs. This approach is a novel method for risk stratification and emphasizes shared decision-making for early detection and management of pa... The study findings will be published in peer-reviewed publications and disseminated at national and international conferences and through social media. This study was approved by the institutional rev... [cris.nih.go.kr], identifier (KCT0007881)....

Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.

In recent years, immune checkpoint inhibitors have been used in combination with tyrosine kinase inhibitors and local therapies, creating a new era in treating hepatocellular carcinoma (HCC) with port... This study enrolled patients receiving triple therapy at four institutions between August 2018 and April 2022. Patient characteristics and course of treatment were extracted from patient records. Tumo... Median follow-up duration was 18 (4.0-26.3) months. Overall, 41 patients with HCC and Vp4 receiving first-line triple therapy were enrolled. The intrahepatic tumor objective response rate was 68.3%. T... TACE plus lenvatinib and PD-1 inhibition was effective and tolerable for treating unresectable HCC with Vp4, with a high tumor response rate and favorable prognosis....

The impact of a structured assessment and decision tool (I-DECIDED®) on improving care of peripheral intravenous catheters: A multicenter, interrupted time-series study.

Peripheral intravenous catheters are the most widely used invasive device in hospitals but have serious risks.... To determine if a structured assessment and decision tool (I-DECIDED®) improves daily peripheral intravenous catheter assessment and care decisions.... Prospective, interrupted time-series study.... Seven adult inpatient wards in three Australian hospitals.... 825 adults with 867 peripheral intravenous catheters.... Between August 2017 and December 2018, peripheral intravenous catheter assessments and chart audits were undertaken with informed patient consent. Following a 4-month pre-intervention period (with 2-w... Of 2055 patients screened, 1175 (57.2%) had a peripheral intravenous catheter, and 825 patients (867 catheters) consented and were included in the final analysis. Device utilization increased from 42.... Implementation of a comprehensive device assessment and decision tool (I-DECIDED®) reduced idle catheters and catheter complications, despite higher device utilization. Dressing quality improved but w... ACTRN12617000067370. Date of registration 13 January 2017. Date of first data collection 3rd August 2017.... #IDECIDEDassessment reduces prevalence of idle peripheral catheters and device complications....

A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.

Accurate prediction of response to neoadjuvant chemoradiotherapy is critical for subsequent treatment decisions for patients with locally advanced rectal cancer.... To develop and validate a deep learning model based on the comparison of paired MRI before and after neoadjuvant chemoradiotherapy to predict pathological complete response.... By capturing the changes from MRI before and after neoadjuvant chemoradiotherapy in 638 patients, we trained a multitask deep learning model for response prediction (DeepRP-RC) that also allowed simul... Multicenter study.... We retrospectively enrolled 1201 patients diagnosed with locally advanced rectal cancer who underwent neoadjuvant chemoradiotherapy before total mesorectal excision. Patients had been treated at 1 of ... The main outcome was the accuracy of predicting pathological complete response, measured as the area under receiver operating curve for the training and validation data sets.... DeepRP-RC achieved high performance in predicting pathological complete response after neoadjuvant chemoradiotherapy, with area under the curve values of 0.969 (0.942-0.996), 0.946 (0.915-0.977), 0.94... This study was limited by its retrospective design and absence of multiethnic data.... DeepRP-RC could be an accurate preoperative tool for pathological complete response prediction in rectal cancer after neoadjuvant chemoradiotherapy.... ANTECEDENTES:La predicción precisa de la respuesta a la quimiorradioterapia neoadyuvante es fundamental para las decisiones de tratamiento posteriores para los pacientes con cáncer de recto localmente...

Infarct severity and outcomes in ST-elevation myocardial infarction patients without standard modifiable risk factors - A multicenter cardiac magnetic resonance study.

Standard modifiable cardiovascular risk factors (SMuRFs) are well-established players in the pathogenesis of ST-elevation myocardial infarction (STEMI). However, in a significant proportion of STEMI p... To assess the infarct characteristics at myocardial-tissue level and subsequent clinical outcomes in SMuRF-less STEMIs.... This multicenter, individual patient-data analysis included 2012 STEMI patients enrolled in four cardiac magnetic resonance (CMR) imaging studies conducted in Austria, Germany, Scotland, and the Nethe... No SMuRF was identified in 185 patients (9%). These SMuRF-less patients were older, more often male, had lower TIMI risk score and pre-interventional TIMI flow, and less frequently multivessel-disease... In this large individual patient-data pooled analysis of low-risk STEMI patients, infarct characteristics and clinical outcomes were not different according to SMuRF status....

MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial.

Traumatic brain injury (TBI) is a significant cause of death and disability, with no effective neuroprotective drugs currently available for its treatment. Mesenchymal stromal cell (MSC)-based therapy... The study will be conducted in two steps. Step 1 will enrol 42 patients, randomised in a 1:1:1 ratio to receive 80 million MSCs, 160 million MSCs or a placebo to establish safety and identify the most... Overall, the MATRIx trial is a critical step towards developing an effective treatment for TBI, which could significantly improve the lives of millions worldwide affected by this debilitating conditio...

Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study.

Allogeneic hematopoietic cell transplantation (allo-HCT) remains the sole curative option for myelofibrosis (MF). Relapse remains a significant problem, however, occurring in up to 20% to 30% of cases...

Clinical Outcomes and Predictors of Long-Term Survival in Patients With and Without Previously Known Extracardiac Sarcoidosis Using Machine Learning: A Swedish Multicenter Study.

Background Cardiac involvement can be an initial manifestation in sarcoidosis. However, little is known about the association between various clinical phenotypes of cardiac sarcoidosis (CS) and outcom...